Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Screening Patients at High Risk for Pancreatic Cancer

Clin Gastroenterol Hepatol; ePub 2018 May 15; Corral, et al

135 patients at high-risk for pancreatic cancer must be screened to identify 1 patient with a high-risk pancreatic lesion, based on findings from a recent meta-analysis that sought to determine the diagnostic yield and outcomes of abdominal imaging screening for asymptomatic individuals at high risk. The primary outcome was identification of high-risk pancreatic lesions at initial screening and overall incidence at follow-up. Among the details:

  • 19 studies comprising 7,085 individuals at high risk for pancreatic cancer were included; of these, 1,660 were evaluated by endoscopic ultrasound (EUS) and/or MRI.
  • 59 high-risk lesions were identified and 257 patients underwent pancreatic surgery.
  • The overall diagnostic yield screening for high-risk pancreatic lesions was 0.74 with moderate heterogeneity among studies.
  • The number needed to screen to identify 1 patient with a high-risk lesion was 135.

Citation:

Corral JE, Mareth KF, Riegert-Johnson DL, Das A, Wallace MB. Diagnostic yield from screening asymptomatic individuals at high risk for pancreatic cancer: A meta-analysis of cohort studies. [Published online ahead of print May 15, 2018]. Clin Gastroenterol Hepatol. doi:10.1016/j.chg.2018.04.065.